Even with effective immune reconstitution and the regain of high counts of clusters of differentiation 4 (CD4) cells with antiretroviral therapy (ART), HIV-positive patients have a 16 times (uncertainty interval 14–18) higher risk of developing TB during the course of the disease as compared to the background risk in the general population [5]. The gene discussed is CD4; the disease is tuberculosis.